Sepsis & infection

Impact of renal vein doppler ultrasound-guided central venous pressure (CVP) titration in sepsis: a pilot randomized controlled trial

Crit CarePublished Randomised controlled trial

Authors' conclusion

In this pilot randomized controlled trial, renal vein Doppler ultrasound-guided CVP titration was feasible and was associated with greater de-escalation and a lower fluid balance.

Study context

Population
Adults with sepsis and CVP monitoring in an ICU, April–December 2023173 screened
Participants
127 adults
Comparison
Renal vein Doppler-guided CVP titration vs usual care
  • RVD-CVPn = 63
  • Usual caren = 64reference
Primary endpoint
Feasibility: complete protocol delivery in the intervention group
Methodological detailspilot, prospective, single-centre, parallel-group
  • Pilot
  • Prospective
  • Single-centre
  • Parallel-group

Primary result

As reported in the abstract

Complete protocol delivery, intervention patients

100.0%

63/63; 95% CI, 94.3–100.0

Scheduled renal vein Doppler assessments completed (315/315)

100.0%

Secondary outcomes

AKI progression within 7 days (exploratory)

Control 37/64 vs intervention 27/63
57.0% vs. 43.0%
RR
0.74 (95% CI 0.52-1.06)
  • Exploratory

RRT initiation (exploratory)

Intervention vs control
9.52% vs. 23.44%
RR
0.41 (95% CI 0.17-0.98, P = 0.035)
  • Exploratory

Duration of RRT (exploratory)

Intervention vs control (P = 0.03)
0.84 days vs. 2.39 days
  • Exploratory

Mortality (exploratory) · 28 days

Intervention vs control
7.9% vs. 12.5%
  • Exploratory

Vasopressor-free days at day 28 (exploratory)

Intervention vs control, mean (days)
22.12 vs. 18.84
  • Exploratory

Maximum norepinephrine dose (exploratory)

Intervention vs control, mean (µg/kg/min)
0.423 vs. 0.560
  • Exploratory

Safety

Safety-override deferrals

Deferrals in 17/315 assessments
5.4%

Original publication

Impact of renal vein doppler ultrasound-guided CVP titration in sepsis: a pilot randomized controlled trial. Crit Care. Published 24 January 2026. doi:10.1186/s13054-026-05842-z

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.